Home › Funds › H&F Corporate Investors X, Ltd. › MDLN
H&F Corporate Investors X, Ltd. position in MDLN
MEDLINE INC · Health Care
H&F Corporate Investors X, Ltd. reported holding 70,874,326 shares of MDLN (MEDLINE INC) in its Q3 2026 13F filing — a position valued at US$2.46B, representing 100.00% of its reported portfolio and ranking #1 among its reported holdings. H&F Corporate Investors X, Ltd. has disclosed MDLN holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How H&F Corporate Investors X, Ltd.'s MDLN position evolved
H&F Corporate Investors X, Ltd. first disclosed a stake in MDLN in Q4 2025 at 99,514,069 shares (US$4.18B). Across 4 filings, H&F Corporate Investors X, Ltd. increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 70,874,326 shares valued at US$2.46B.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 99.51M | $4.18B | New |
| Q1 2026 | 86.47M | $3.85B | Reduce |
| Q2 2026 | 70.87M | $2.80B | Reduce |
| Q3 2026 | 70.87M | $2.46B | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MDLN and 13F data
MDLN (MEDLINE INC) is a Health Care company. 93 other funds we track also report a position in MDLN — the largest reported positions include Carlyle Group Inc. (US$6.49B), Blackstone Inc. (US$4.01B), Lone Pine Capital (US$827.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MDLN
- Carlyle Group Inc. 187.08M sh · $6.49B · Q3 2026
- Blackstone Inc. 101.79M sh · $4.01B · Q2 2026
- Lone Pine Capital 20.97M sh · $826.99M · Q2 2026
- LONE PINE CAPITAL LLC 20.97M sh · $826.99M · Q2 2026
- Egerton Capital (UK) LLP 13.28M sh · $460.92M · Q3 2026
- SurgoCap Partners LP 7.49M sh · $295.31M · Q2 2026
- HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND 7.36M sh · $290.10M · Q2 2026
- Alyeska Investment Group, L.P. 6.81M sh · $268.55M · Q2 2026
- BANQUE PICTET & CIE SA 7.46M sh · $258.69M · Q3 2026
- Unisphere Establishment 3.68M sh · $145.24M · Q2 2026
- SEVEN GRAND MANAGERS, LLC 3.65M sh · $144.00M · Q2 2026
- Ghisallo Capital Management LLC 3.00M sh · $118.32M · Q2 2026
More on H&F Corporate Investors X, Ltd.
FAQ
How long has H&F Corporate Investors X, Ltd. held MDLN?
H&F Corporate Investors X, Ltd. has disclosed MDLN holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is H&F Corporate Investors X, Ltd.'s current position in MDLN?
As of Q3 2026, H&F Corporate Investors X, Ltd. holds 70.87M shares of MDLN (MEDLINE INC), valued at $2.46B, representing 100.00% of its reported portfolio and ranking #1.
Has H&F Corporate Investors X, Ltd. been buying or selling MDLN?
In the latest 13F filing (Q3 2026), H&F Corporate Investors X, Ltd. held unchanged its position in MDLN.
Which other funds hold MDLN?
Other major institutional holders of MDLN include Carlyle Group Inc., Blackstone Inc., Lone Pine Capital, among 93 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.